Is it safe?
Can INVA take a bad year?
Innoviva, Inc. holds $345M more cash than debt, so a bad year is a question about profits, not about lenders.
$345M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 3.55
Altman Z-score · safe zone, above 3
- Interest cover
- 9.21×
Interest cover · operating profit covers the interest bill several times over
Details›
- Total debtQ1 2026
- $258M
- Cash and short-term investments
- $603M
- Net cash
- $345M
- EBITDA, trailing twelve months
- $187M
- Operating profit, trailing twelve months
- $160M
- Debt / equity
- 0.19×
- Total debt / EBITDA
- 1.38×
- Annualised volatilitytwo years of daily moves
- 24%
- Worst drawdown on file
- −60%
- Below its 52-week high
- −12%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Biotechnology
Ranks #24 of 145 by Smart Score